The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 28-34

  Lim, Myong Cheol ^a,b   Kang, Sokbom ^a   Lee, Kyung Soo ^a   Han, Sung Sik ^a   Park, Sang Jae ^a   Seo, Sang Soo ^a   Park, Sang Yoon ^a  

^a National Cancer Center   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Hepatectomy; Ovarian cancer; Primary cytoreductive surgery; Residual tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HEMIHEPATECTOMY; HISTOLOGY; HUMAN; LIVER PARENCHYMA; MAJOR CLINICAL STUDY; METASTASIS; OVARY CANCER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SEGMENTECTOMY;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LIVER NEOPLASMS; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; OVARIAN NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 57649149229     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.09.046     Document Type: Article

References (25)

1. Greenlee R.T., Hill-Harmon M.B., Murray T., and Thun M. Cancer statistics, 2001. CA Cancer J. Clin. 51 (2001) 15-36
2. Chung H.H., Hwang S.Y., Jung K.W., Won Y.J., Shin H.R., Kim J.W., et al. Ovarian cancer incidence and survival in Korea: 1993-2002. Int. J. Gynecol. Cancer 17 (2007) 595-600
3. Chi D.S., Franklin C.C., Levine D.A., Akselrod F., Sabbatini P., Jarnagin W.R., et al. Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. Gynecol. Oncol. 94 (2004) 650-654
4. Zivanovic O., Eisenhauer E.L., Zhou Q., Iasonos A., Sabbatini P., Sonoda Y., et al. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer. Gynecol. Oncol. 108 (2008) 287-292
5. Rose P.G., Piver M.S., Tsukada Y., and Lau T.S. Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer 64 (1989) 1508-1513
6. International Federation of Gynecology and Obstetrics (FIGO) Cancer Committee. Staging announcement. Gynecol Oncol. 25 (1986) 383-385
7. Park K.M. Hepatectomy for metastatic colorectal carcinoma: single center experience. Cancer Res. Treat. 36 (2004) 39s-s
8. Kuvshinoff B., and Fong Y. Surgical therapy of liver metastases. Semin. Oncol. 34 (2007) 177-185
9. Weitz J., Blumgart L.H., Fong Y., Jarnagin W.R., D'Angelica M., Harrison L.E., et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann. Surg. 241 (2005) 269-276
10. Kim J.C., Kim C.N., Yu C.S., Lee H.I., Kim S.W., Lee J.W., et al. Treatment of hepatic metastasis of colorectal cancer: a retrospective analysis of the outcome in 99 patients. Cancer Res. Treat. 1998 (1998) 1175-1184
11. Scarabelli C., Gallo A., and Carbone A. Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma. Gynecol. Oncol. 83 (2001) 504-512
12. Chi D.S., Fong Y., Venkatraman E.S., and Barakat R.R. Hepatic resection for metastatic gynecologic carcinomas. Gynecol. Oncol. 66 (1997) 45-51
13. Merideth M.A., Cliby W.A., Keeney G.L., Lesnick T.G., Nagorney D.M., and Podratz K.C. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol. Oncol. 89 (2003) 16-21
14. Akin O., Sala E., Moskowitz C.S., Ishill N., Soslow R.A., Chi D.S., et al. Perihepatic metastases from ovarian cancer: sensitivity and specificity of CT for the detection of metastases with and those without liver parenchymal invasion. Radiology 248 (2008) 511-517
15. Kim S.H., Park S.J., Lee S.A., Lee W.J., Park J.W., Hong E.K., et al. Various liver resections using hanging maneuver by three Glisson's pedicles and three hepatic veins. Ann. Surg. 245 (2007) 201-205
16. Morice P., Camatte S., Lhomme C., Duvillard P., and Castaigne D. [Management of advanced stage ovarian cancer]. Rev. Prat. 54 (2004) 1777-1786
17. Eitan R., Levine D.A., Abu-Rustum N., Sonoda Y., Huh J.N., Franklin C.C., et al. The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma. Cancer 103 (2005) 1397-1401
18. Winter III W.E., Maxwell G.L., Tian C., Sundborg M.J., Rose G.S., Rose P.G., et al. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J. Clin. Oncol. 26 (2008) 83-89
19. Brunschwig A. Hepatic lobectomy for metastatic cancer. Cancer 16 (1963) 277-282
20. Harrison L.E., Brennan M.F., Newman E., Fortner J.G., Picardo A., Blumgart L.H., et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery 121 (1997) 625-632
21. Foster J.H. History of liver surgery. Arch. Surg. 126 (1991) 381-387
22. Abood G., Bowen M., Potkul R., Aranha G., and Shoup M. Hepatic resection for recurrent metastatic ovarian cancer. Am. J. Surg. 195 (2008) 370-373 discussion 3
23. Yoon S.S., Jarnagin W.R., Fong Y., DeMatteo R.P., Barakat R.R., Blumgart L.H., et al. Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecol. Oncol. 91 (2003) 383-388
24. Aletti G.D., Dowdy S.C., Gostout B.S., Jones M.B., Stanhope C.R., Wilson T.O., et al. Aggressive surgical effort and improved survival in advanced-stage ovarian cancer. Obstet. Gynecol. 107 (2006) 77-85
25. Eisenhauer E.L., Abu-Rustum N.R., Sonoda Y., Levine D.A., Poynor E.A., Aghajanian C., et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol. Oncol. 103 (2006) 1083-1090